Physician

Yungpo B Su, MD

According to 2025 Medicare claims, Yungpo Su, MD (NPI: 1457322166) practices hematology/oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Su is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Su's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 204,436 HCPCS/CPT codes, and received $3,269,149 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,093 prescription claims across 174 beneficiaries totaling $360,242 in drug costs, led by Potassium Chloride (Potassium Chloride). 2023 DME data shows 56 claims. Open Payments data shows 39 records totaling $128,128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $861,442 to $3,269,149. Similarly, Part D prescription costs have moved sharply higher in recent years, from $124,410 to $360,242. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	179,950	$861,442
2016	591	192,855	$1,180,827
2017	585	182,351	$1,300,569
2018	580	168,225	$1,656,875
2019	615	156,193	$1,869,056
2020	623	130,238	$1,408,641
2021	578	154,069	$1,579,854
2022	590	146,180	$1,747,153
2023	599	150,454	$2,656,750
2024	609	204,436	$3,269,149

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	96	380	$124,410
2016	89	475	$35,921
2017	91	478	$28,129
2018	101	624	$11,960
2019	106	589	$18,554
2020	116	661	$34,767
2021	133	788	$48,161
2022	138	852	$172,183
2023	139	842	$144,038
2024	174	1,093	$360,242

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	32	230	$18,083
2016	N/R	90	$5,386
2017	N/R	31	$2,967
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	118	$71,512
2022	N/R	66	$2,601
2023	N/R	56	$1,178
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	114	177	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	232	685	$87
96413	Administration of chemotherapy into vein, 1 hour or less	120	477	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	94	106	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	147	170	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Potassium Chloride	Potassium Chloride	41	1,606	$3,037
Levothyroxine Sodium	Levothyroxine Sodium	368	19,560	$2,541
Dexamethasone	Dexamethasone	60	961	$1,109
Synthroid	Levothyroxine Sodium	20	900	$1,010
Prochlorperazine Maleate	Prochlorperazine Maleate	67	580	$599

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$107	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	34	$128,021	NEBRASKA METHODIST HOSPITAL
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yungpo B. Su, MD?

Tedicare shows public-source Medicare data for Yungpo B. Su, MD (NPI 1457322166), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yungpo B. Su, MD have ACO affiliation data?

Yungpo B. Su, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Yungpo B. Su, MD?

Yungpo B. Su, MD is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Yungpo B. Su, MD have Open Payments data?

Yungpo B. Su, MD has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.